Ireland
--:--IST
Active, not recruiting Not applicable

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

NCT06701032 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-11-25
Last updated
2026-06-12

Condition(s) studied

Peripheral Artery Disease (PAD)Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Cerebrovascular Atherosclerosis

Investigational drug(s) / intervention(s)

Cardiovascular rehabilitation program

Cardiovascular rehabilitation program: The cardiovascular rehabilitation program consists of a 12 weeks supervised exercises therapy (either in person or in tele-care)

Study summary

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).

Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic); * Have been admitted to the PREV program; Exclusion Criteria: * Being not able to give written informed consent;

Primary outcome measure(s)

  • Change in toe pressure measurement — Change from baseline to 12 weeks
    Results will be measured in mm Hg
  • Change in the toe-brachial index — Change from baseline to 12 weeks
  • Change in the ankle-brachial index — Change from baseline to 12 weeks

Trial sites (1)

FacilityCityRegionStatus
CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches Lévis Quebec
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06701032 on ClinicalTrials.gov ↗ ← All trials in Canada